ROOTPATH GENOMICS
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
ROOTPATH GENOMICS
Social Links:
Industry:
Biotechnology
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.rootpath.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
68 M USD
Technology used in webpage:
Viewport Meta SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Google Apps For Business AJAX Libraries API Typekit
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Armonica
Armonica is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
NAVAN Technologies
NAVAN Technologies is a privately-held biotechnology company enabling the development of next generation cell and gene therapies
Stem Cell & Device Laboratory
Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.
StemoniX
StemoniX is a biotechnology company that focuses on stem cell technologies to meet the demands of drug discovery and personalized medicine.
Verigraft AB
Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine.
Current Employees Featured
Founder
Investors List
Sky9 Capital
Sky9 Capital investment in Series B - RootPath Genomics
Matrix Partners China
Matrix Partners China investment in Series B - RootPath Genomics
CDH Investments
CDH Investments investment in Series B - RootPath Genomics
Hony Capital
Hony Capital investment in Series B - RootPath Genomics
Baidu Ventures
Baidu Ventures investment in Series A - RootPath Genomics
Volcanics Venture
Volcanics Venture investment in Series A - RootPath Genomics
Sequoia Capital China
Sequoia Capital China investment in Series A - RootPath Genomics
Matrix Partners China
Matrix Partners China investment in Series A - RootPath Genomics
Nest.Bio Ventures
Nest.Bio Ventures investment in Series A - RootPath Genomics
Oriza Seed Capital (Oriza Yuandian)
Oriza Seed Capital (Oriza Yuandian) investment in Series A - RootPath Genomics
Official Site Inspections
http://www.rootpath.com
- Host name: 104.19.240.93
- IP address: 104.19.240.93
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RootPath Genomics"
RootPath - Crunchbase Company Profile & Funding
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and โฆSee details»
RootPath
RootPath is a synthetic biology company. We elevate the throughput of gene function interrogation by orders of magnitude. Our molecular programming-based DNA fragment โฆSee details»
RootPath Genomics Company Profile - Office Locations ... - Craft
RootPath Genomics has 5 employees across 3 locations and $7 m in total funding,. See insights on RootPath Genomics including office locations, competitors, revenue, financials, executives, โฆSee details»
RootPath Company Profile | Management and Employees List
RootPath Profile and History. RootPath is a preclinical-stage biotechnology company pioneering personalized immunotherapy and cell therapy for solid tumors using its proprietary Synthetic โฆSee details»
RootPath 2025 Company Profile: Valuation, Funding
RootPath General Information Description. Developer of an immune and cell therapy designed to bridge precision medicine and cancer immunotherapy. โฆSee details»
RootPath - VentureRadar
RootPath is a synthetic biology company. We elevate the throughput of gene function interrogation by orders of magnitude. Our molecular programming-based DNA fragment โฆSee details»
ROOTPATH GENOMICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ROOTPATH GENOMICS, INC. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Rootpath Genomics, Inc. - Drug pipelines, Patents, โฆ
Jun 5, 2023 WATERTOWN, Mass.--(BUSINESS WIRE)-- RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced a new publication in Nature โฆSee details»
RootPath Launches, Elevating Throughput of Gene โฆ
Mar 21, 2022 RootPath was incubated and founded by Nest.bio Ventures in 2017 and has since raised more than $60 million from renowned investors such as Sequoia Capital China, CDH Investment and Sky9 Capital.See details»
RootPath - Org Chart, Teams, Culture & Jobs - The Org
View RootPath's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Rootpath
RootPath is a synthetic biology company. We elevate the throughput of gene function interrogation by orders of magnitude. Our molecular programming-based DNA fragment โฆSee details»
RootPath - Profiles & Contacts - Crunchbase
RootPath has 5 current employee profiles, including Co-founder and Chief Executive Officer Xi Chen. Employee Profiles 5. Contacts 6. Employee Profiles. Number of Employee Profiles 5. Xi โฆSee details»
Root Path - Biotech Careers
RootPath is a Cambridge-based biotechnology company developing a personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Business Areas: โฆSee details»
RootPath | VentureRadar
RootPath is a synthetic biology company. We elevate the throughput of gene function interrogation by orders of magnitude. Our molecular programming-based DNA fragment โฆSee details»
Rootpath Genomics, Inc. (Rootpath Genomics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Jun 15, 2025 About RootPath RootPath is a synthetic biology company that aims to elevate the throughput of gene function interrogation by orders of magnitude. Our Molecular Programming โฆSee details»
RootPath - Growth Outlook - Crunchbase
RootPath is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine. Founded 2017 Private Venture ... Organization Name . โฆSee details»
RootPath - Funding, Financials, Valuation & Investors - Crunchbase
RootPath is funded by 12 investors. Guanghua Wutong Fund and Si Chuan Venture Capital are the most recent investors. RootPath has a post-money valuation in the range of $10M to $50M โฆSee details»
RootPath
Blake is the founder of RootPath Capital. For more than 20 years, heโs helped small businesses grow โ as an operator, investor, and strategist. From leading go-to-market and strategy at โฆSee details»
RootPath Home Page
Welcome to RootPath Customer Portal! We enable biology at scale. © 2023 RootPath, Inc ๆตICPๅค2023037826ๅท All rights reserved. ๆตICPๅค2023037826ๅท All rights ...See details»
RootPath raises $50m - volcanics.com
Sep 26, 2021 RootPath Genomics, a preclinical-stage biotech firm that develops personalised immunotherapy and cell therapy for solid tumours, has raised $50 million in a Series B โฆSee details»